How can doctors discuss CLL treatment options with patients?
Paediatric treatment regimens for acute lymphoblastic leukaemia in adolescents and young adults
Novel issues in the combined modality treatment of lymphomas
Relapse in DLBCL - addressing the unmet need with brentuximab vedotin
Results of the German acute myeloid leukemia (AML) intergroup study